相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immune-related Adverse Events Associated With Checkpoint Inhibition in the Setting of CAR T Cell Therapy: A Case Series
Swetha Kambhampati et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)
Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma
Sarah Abou Alaiwi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Management of immune checkpoint inhibitor-related dermatologic adverse events
Xiaoyan Si et al.
THORACIC CANCER (2020)
Cutaneous adverse effects of biologic medications
Selena R. Pasadyn et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2020)
Cardiotoxicity danger in immunotherapy
Beata Jagielska et al.
IUBMB LIFE (2020)
Cytokine Storm
David C. Fajgenbaum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cytokines in CAR T Cell-Associated Neurotoxicity
Juliane Gust et al.
FRONTIERS IN IMMUNOLOGY (2020)
Pembrolizumab-Induced Diabetes Mellitus Presenting as Diabetic Ketoacidosis in a Patient With Metastatic Colonic Adenocarcinoma
Asim Kichloo et al.
JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS (2020)
Oncologic Emergencies: Immune-Based Cancer Therapies and Complications
Brit Long et al.
WESTERN JOURNAL OF EMERGENCY MEDICINE (2020)
Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors
Juwhan Choi et al.
IMMUNE NETWORK (2020)
Risk and incidence of fatal adverse events associated with immune checkpoint inhibitors: a systematic review and meta-analysis
Yi Jiang et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2019)
The Impact of High-Dose Glucocorticoids on the Outcome of Immune-Checkpoint Inhibitor-Related Thyroid Disorders
Chanjuan Ma et al.
CANCER IMMUNOLOGY RESEARCH (2019)
A good start of immunotherapy in esophageal cancer
Qian Zhao et al.
CANCER MEDICINE (2019)
Tyrosine kinase inhibitors and immune checkpoint inhibitors-induced thyroid disorders
Arnaud Jannin et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Cardiotoxicity of Immune Therapy
Sarju Ganatra et al.
CARDIOLOGY CLINICS (2019)
Immune checkpoint inhibitor-associated pituitary-adrenal dysfunction: A systematic review and meta-analysis
Jingli Lu et al.
CANCER MEDICINE (2019)
Cancer Treatment-Associated Pericardial Disease: Epidemiology, Clinical Presentation, Diagnosis, and Management
Chandra K. Ala et al.
CURRENT CARDIOLOGY REPORTS (2019)
Management of pulmonary toxicity associated with immune checkpoint inhibitors
Myriam Delaunay et al.
EUROPEAN RESPIRATORY REVIEW (2019)
Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Neurologic Toxicity: Illustrative Case and Review of the Literature
Kerry L. Reynolds et al.
ONCOLOGIST (2019)
An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer
Steven Feins et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Hypophysitis in the era of immune checkpoint inhibitors and immunoglobulin G4-related disease
Leen Wehbeh et al.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2019)
Management of Gastrointestinal Toxicity from Immune Checkpoint Inhibitor
Marta Rocha et al.
GE PORTUGUESE JOURNAL OF GASTROENTEROLOGY (2019)
Cascade of immunologic adverse events related to pembrolizumab treatment
Arnaud Dhenin et al.
BMJ CASE REPORTS (2019)
Immune checkpoint inhibitor colitis: the flip side of the wonder drugs
Naziheh Assarzadegan et al.
VIRCHOWS ARCHIV (2018)
Thyroid dysfunctions secondary to cancer immunotherapy
P. Chalan et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2018)
Cardiotoxicities associated with immune checkpoint inhibitors
Shu Yang et al.
CURRENT PROBLEMS IN CANCER (2018)
Programmed Cell Death-1 Inhibitor-Induced Type 1 Diabetes Mellitus
Katrien Clotman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Lessons learned from the blockade of immune checkpoints in cancer immunotherapy
Xiaolei Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Gastrointestinal toxicity of immune checkpoint inhibitors: from mechanisms to management
Mark A. Samaan et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Cancer immunotherapy: broadening the scope of targetable tumours
Jitske van den Bulk et al.
OPEN BIOLOGY (2018)
Immunotherapy-Induced Colitis: An Emerging Problem for the Hospitalist
Julian A. Marin-Acevedo et al.
JOURNAL OF HOSPITAL MEDICINE (2018)
Neurological complications of immune checkpoint inhibitors: what happens when you take the brakes off' the immune system
Marinos C. Dalakas
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2018)
Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitis
Sarah Chuzi et al.
CANCER MANAGEMENT AND RESEARCH (2017)
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
I. Puzanov et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Biological agents in gastrointestinal cancers: adverse effects and their management
Nivedita Arora et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2017)
PD-1 Inhibitor-Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical Course
Mizuki Nishino et al.
CLINICAL CANCER RESEARCH (2016)
Cancer-induced heterogeneous immunosuppressive tumor microenvironments and their personalized modulation
Tomonori Yaguchi et al.
INTERNATIONAL IMMUNOLOGY (2016)
Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease
L. Marthey et al.
JOURNAL OF CROHNS & COLITIS (2016)
Risk of grade 3-4 diarrhea and mucositis in colorectal cancer patients receiving anti-EGFR monoclonal antibodies regimens: A meta-analysis of 18 randomized controlled clinical trials
Marco Miroddi et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
Therapeutic cancer vaccines
Cornelis J. M. Melief et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Cancer immunotherapy: harnessing the immune system to battle cancer
Yiping Yang
JOURNAL OF CLINICAL INVESTIGATION (2015)
Cardiotoxicity of anticancer treatments
Michael S. Ewer et al.
NATURE REVIEWS CARDIOLOGY (2015)
Current concepts in the diagnosis and management of cytokine release syndrome
Daniel W. Lee et al.
BLOOD (2014)
Immune modulation for cancer therapy
J. Naidoo et al.
BRITISH JOURNAL OF CANCER (2014)
Bevacizumab increases the risk of gastrointestinal perforation in cancer patients: a meta-analysis with a focus on different subgroups
Wei-Xiang Qi et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Risk of gastrointestinal perforation in cancer patients treated with aflibercept: a systematic review and meta-analysis
Wei-Xiang Qi et al.
TUMOR BIOLOGY (2014)
Adoptive T-cell therapy: adverse events and safety switches
Siok-Keen Tey
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2014)
MULTIFOCAL RADICULONEUROPATHY DURING IPILIMUMAB TREATMENT OF MELANOMA
Georgios Manousakis et al.
MUSCLE & NERVE (2013)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
Richard A. Morgan et al.
MOLECULAR THERAPY (2010)
Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity
LP Chen
NATURE REVIEWS IMMUNOLOGY (2004)
分享论文
